ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
42408.1 IP-LS
Project title
Novel cancer therapeutics targeting carbohydrate antigens
Project status Finished
 
Start date 01.02.2020
End date 01.02.2022
 
Granted total costs 867'386.00  CHF
Section 60 Life Sciences
Project category Project
Research type Applied research and development
NABS classification Industrial production and technology
 
Research disciplines
100 % T410 Pharmaceuticals and related technologies
Last modification of the project